These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38941485)

  • 1. Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations.
    Gleeson JP; Zhang SY; Subelzu N; Ling J; Nissley B; Ong W; Nofsinger R; Kesisoglou F
    Mol Pharm; 2024 Jun; ():. PubMed ID: 38941485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
    Zhang SY; Ong WSY; Subelzu N; Gleeson JP
    Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.
    Kneiszl R; Hossain S; Larsson P
    Mol Pharm; 2022 Jan; 19(1):124-137. PubMed ID: 34913341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences and Translatability of
    Emeh P; Breitholtz K; Berg S; Vedin C; Englund M; Uggla T; Antonsson M; Nunes F; Hilgendorf C; Bergström CAS; Davies N
    Mol Pharm; 2024 Jan; 21(1):313-324. PubMed ID: 38054599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?
    Bohley M; Leroux JC
    Adv Sci (Weinh); 2024 Jun; ():e2400843. PubMed ID: 38884149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
    Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
    Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
    Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
    Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic chip for culturing intestinal epithelial cell layers: Characterization and comparison of drug transport between dynamic and static models.
    Kulthong K; Duivenvoorde L; Sun H; Confederat S; Wu J; Spenkelink B; de Haan L; Marin V; van der Zande M; Bouwmeester H
    Toxicol In Vitro; 2020 Jun; 65():104815. PubMed ID: 32119998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments.
    Larsen NW; Kostrikov S; Hansen MB; Hjørringgaard CU; Larsen NB; Andresen TL; Kristensen K
    Int J Pharm; 2024 Apr; 654():123957. PubMed ID: 38430950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.
    Kollipara S; Gandhi RK
    Acta Pharm Sin B; 2014 Oct; 4(5):333-49. PubMed ID: 26579403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
    Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
    Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation strategies to improve the efficacy of intestinal permeation enhancers
    Maher S; Brayden DJ
    Adv Drug Deliv Rev; 2021 Oct; 177():113925. PubMed ID: 34418495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labrafac
    McCartney F; Caisse P; Dumont C; Brayden DJ
    Int J Pharm; 2024 Jun; 661():124353. PubMed ID: 38909926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of simulated intestinal fluids with Caco-2 cells and rat ileum.
    Patel N; Forbes B; Eskola S; Murray J
    Drug Dev Ind Pharm; 2006 Feb; 32(2):151-61. PubMed ID: 16537196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.
    Dahlgren D; Sjöblom M; Hedeland M; Lennernäs H
    Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 31991924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
    Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
    Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro, Ex Vivo and In Vivo Evaluation of Microcontainers for Oral Delivery of Insulin.
    Jørgensen JR; Yu F; Venkatasubramanian R; Nielsen LH; Nielsen HM; Boisen A; Rades T; Müllertz A
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31936066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips.
    J Vis Exp; 2019 May; (147):. PubMed ID: 31067212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
    Brayden DJ; Stuettgen V
    Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.